Analysis of Intramedullary Nail and Prosthetic Reconstruction After Surgical Treatment of Bone Metastases of Proximal Femur
Complications, Implant Survival and Functional Results After Surgical Treatment of Bone Metastases of Proximal Femur With Intramedullary Nail or Prosthetic Reconstruction
Costantino Errani
600 participants
May 30, 2024
OBSERVATIONAL
Conditions
Summary
The investigators will collect data of patients treated surgically for impending or pathological fracture of the proximal femur due to bone metastases between 01/01/2000 and 31/12/2023 with IMN or THA or HHA or MegaTHA or Mega. After pre-screening the databases of the respective sites, the investigators expect to find approximately a total of 600 patients. A review will be made from the medical records, radiological imaging, and histological data of partecipants.
Eligibility
Inclusion Criteria5
- Male and female adult patients surgically treated between 01/01/2000 and 31/12/2023 in Rizzoli Orthopaedic Institute and in Massachusetts General Hospital.
- Age ≥18 y (at the time of surgery)
- Patients with impending or pathological fracture due to bone metastases of the proximal femur (head/neck, intertrochanteric, subtrochanteric area).
- Patients who underwent either IMN or THA or HHA or Mega or MegaTHA.
- Patients with available clinical and imaging data.
Exclusion Criteria1
- Patients with pathological or impending fracture of proximal femur due to primary bone tumor.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Analysis and review of imaging and clinical data
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06918860